Dr. Melanie Carter, BScPharm, ACPR, PharmD
Clinical Pharmacy Specialist—Cardiology Kelowna General Hospital, Interior Health
This will be an update on new evidence and therapies in cardiology focusing on the SPRINT trial and sacubitril/ valsartan (Entresto). Time will also be spent addressing the clinical controversy of duration of ACE-I/ARB and BB therapy after acute coronary syndrome.
